Report by
NY Post Highlights SafelyHQs Investigation of Pet Treat Hazards
Jan 11, 2023
The pet industry's growth has been substantial, marked by an increasing demand for premium products that promote the health and wellness of pets. However, the challenge remains in upholding high safety standards across all offerings. SafelyHQ has taken a proactive approach in this regard, employing crowdsourced risk monitoring to identify hazards in the pet treat sector. A recent article in the New York Post has drawn attention to these efforts.
DreamBone, a dog chew product line from Spectrum Brands Holdings, a major conglomerate valued at $3 billion, has been linked to serious illnesses and even deaths in pets. SafelyHQ has become an essential platform for documenting these incidents, playing a pivotal role in bringing this worrying trend to light.
SafelyHQ noticed a significant increase in reports concerning DreamBone. This year alone, our platform logged 70 incidents, almost twice the number reported in 2021. The majority of these reports started coming in from October, indicating a growing problem. Our data analysis pinpointed this surge as an abnormal increase, alarming not just because of the rising number of reports, but also the severity of the incidents.
SafelyHQ leveraged crowdsourcing to unearth and bring attention to a grave risk affecting pet health. Our platform, where pet owners share their experiences, was instrumental in identifying trends and flagging the risks associated with DreamBone treats. This community-driven data was crucial in raising public awareness and prompting investigations by the relevant authorities.
Following our reports, the Food and Drug Administration (FDA) began receiving similar complaints, demonstrating the impact of crowdsourced data in identifying risks and triggering official probes.
SafelyHQ is committed to tracking and reporting on health and safety issues that affect individuals and communities. Our platform, which encourages the sharing of personal experiences, helps users to make better-informed decisions. The importance of real-time monitoring and reporting in the early detection of risks cannot be overstated, as it is key to ensuring safety.
The DreamBone situation highlights the importance of SafelyHQ's role in promoting pet safety. Our focus on crowdsourcing allows for the early detection of threats, fostering preventive measures and enhancing transparency. Our ongoing mission is to build a safer community, one report at a time.
For a comprehensive overview of this case, refer to the original article by the NY Post.
DreamBone, a dog chew product line from Spectrum Brands Holdings, a major conglomerate valued at $3 billion, has been linked to serious illnesses and even deaths in pets. SafelyHQ has become an essential platform for documenting these incidents, playing a pivotal role in bringing this worrying trend to light.
SafelyHQ leveraged crowdsourcing to unearth and bring attention to a grave risk affecting pet health. Our platform, where pet owners share their experiences, was instrumental in identifying trends and flagging the risks associated with DreamBone treats. This community-driven data was crucial in raising public awareness and prompting investigations by the relevant authorities.
SafelyHQ is committed to tracking and reporting on health and safety issues that affect individuals and communities. Our platform, which encourages the sharing of personal experiences, helps users to make better-informed decisions. The importance of real-time monitoring and reporting in the early detection of risks cannot be overstated, as it is key to ensuring safety.
The DreamBone situation highlights the importance of SafelyHQ's role in promoting pet safety. Our focus on crowdsourcing allows for the early detection of threats, fostering preventive measures and enhancing transparency. Our ongoing mission is to build a safer community, one report at a time.
For a comprehensive overview of this case, refer to the original article by the NY Post.